Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
NaviFUS Corporation
Hoffmann-La Roche
Second Affiliated Hospital, School of Medicine, Zhejiang University